BioAge Labs, Inc.
BIOA
$18.19
$0.030.17%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 610.96% | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 610.96% | -- | -- | -- | -- |
| Cost of Revenue | 36.90% | 25.29% | -6.79% | 30.77% | 40.77% |
| Gross Profit | -22.87% | -10.05% | 14.82% | -23.58% | -37.42% |
| SG&A Expenses | 28.08% | 45.16% | 62.96% | 64.89% | 54.44% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.52% | 30.16% | 43.97% | 84.61% | 67.53% |
| Operating Income | -24.30% | -18.65% | -35.06% | -77.11% | -64.62% |
| Income Before Tax | -26.58% | -13.35% | -6.84% | -27.14% | -8.03% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.58% | -13.35% | -6.84% | -27.14% | -8.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.58% | -13.35% | -6.84% | -27.14% | -8.03% |
| EBIT | -24.30% | -18.65% | -35.06% | -77.11% | -64.62% |
| EBITDA | -24.27% | -18.63% | -35.10% | -77.35% | -64.81% |
| EPS Basic | 84.57% | 90.25% | 93.95% | 77.69% | 60.36% |
| Normalized Basic EPS | 84.57% | 90.18% | 92.65% | 73.22% | 52.96% |
| EPS Diluted | 84.57% | 90.25% | 93.95% | 77.69% | 60.36% |
| Normalized Diluted EPS | 84.57% | 90.18% | 92.65% | 73.22% | 52.96% |
| Average Basic Shares Outstanding | 95.10% | 235.09% | 1,578.68% | 1,552.36% | 1,051.67% |
| Average Diluted Shares Outstanding | 95.10% | 235.09% | 1,578.68% | 1,552.36% | 1,051.67% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |